K36 Therapeutics, Inc.

This early-stage trial tests a new drug called KTX-2001, alone or with another drug (darolutamide), in men with metastatic castration-resistant prostate cancer that has spread and stopped responding to hormone therapy. The main goals are to check safety, find the right dose, and …

This early-phase study tests an experimental pill called KTX-1001 in adults with multiple myeloma whose cancer has come back or stopped responding to standard therapies. The main goals are to find a safe dose and see if the drug can shrink tumors or slow the disease. About 165 pa…